According to a recent market study published by Growth Market Reports, titled, “Global Multi-Parameter Vital Sign Monitoring Market is segmented into by device type, by acuity level, by monitoring type, by patient group, by end-use and by region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 8,903.5 Million in 2022 and is expected to grow at a growth rate of 6.3% by the year 2031.

Get Sample Report @

A patient monitor's multiparameter front end global sures vital sign parameters such as electrocardiogram (ECG), heart rate, SpO2, and respiration. Additionally, three TMP117 sensors are used to accurately sure skin temperature. Multi-parameters patient monitors are used to continuously monitor a patient's physiological parameters such as ECG, RESP, SPO2, NIBP, IBP, TEMP, and EtCO2.

It is intended to be used in various hospital rooms, such as the coronary care unit, intensive care unit, neonatal intensive care unit, and operating room to provide additional information about the patient's physiological condition to medical and nursing staff.

Based on device type, the global multi-parameter vital sign monitoring market is segmented into fixed and portable. The portable segment is expected to hold a XX% share of the market in 2022, due to the increasing use of vital sign monitoring devices for the display and record of the important vital signs of the patient. The portable monitoring devices are used bedside or as mobile applications.

On the bases of acuity level, the Global multi-parameter vital sign monitoring market is segmented into high and mid-low acuity level. The high acuity level segment is anticipated to accounts an XX% share of the market in the 2022, due to rising emergency hospital admission, growing critical care surgeries, increasing accident, and traumatic injury cases.

In terms of monitoring type, the Global multi-parameter vital sign monitoring market is segmented into invasive and non-invasive. The invasive segment is projected to hold XX% share of the market in the year 2022, as invasive monitoring involves inserting a probe or catheter directly into the patient's bloodstream, organs, or other body cavities to obtain real-time data on the patient's vital signs, such as blood pressure, oxygenation levels, and cardiac output.

Based on patient group, the global multi-parameter vital sign monitoring market is segmented into geriatric patient group, adult patient group, and paediatric patient group. The geriatric patient group segment is expected to accounts XX% share of the market in the year 2022, as geriatrics refers to medical care for older adults. Growing prevalence of chronic diseases in elderly patients is driving the segment.

In terms of End-use, the global multi-parameter vital sign monitoring market is segmented into hospitals, homecare settings, ambulatory surgical centers, and others. The hospital segment is anticipated to hold a XX% market share in the year 2022, as vital monitoring devices play a vital role in patient monitoring services in hospitals.

The outbreak of COVID-19 has significantly impacted the Global multi-parameter vital sign monitoring market. Many countries in the region have witnessed a surge in the number of COVID-19 cases, leading to a high demand for multi-parameter vital sign monitoring devices. The pandemic has increased the importance of continuous monitoring of vital signs such as heart rate, oxygen saturation, and blood pressure, which are critical indicators in the management of COVID-19 patients.

While it is difficult to give specific statistics on the impact of COVID-19 on deaths related to the Global Multi-Parameter Vital Sign Monitoring market, the World Health Organization (WHO) reports that as of September 13, 2021, the Africa region has reported over 7.8 million confirmed cases and over 197,000 deaths. The highest number of cases and deaths have been reported in South Africa, Tunisia, Egypt, Morocco, and Ethiopia.

As per growth market reports by industry analyst Anuradha More, “Use of multi-parameter vital sign monitoring devices to manage chronic diseases, such as diabetes and heart disease, has become increasingly important in the Global. The burden of chronic diseases is rising, due to lifestyle changes, such as sedentary lifestyles, poor diet, and smoking. Multi-parameter vital sign monitoring devices enable patients to monitor their condition at home, providing vital information to healthcare providers to help manage their disease and prevent complications.”

Supply chain management is an essential part of any business. A supply chain contains a series of steps to get products from their original state to the customers. Raw materials used for manufacturing Product and accessories are shipped to manufacturers for processing into final products. These raw materials include thermistors, blood pressure cuffs, electrodes, adhesive sensors, microcontrollers, display screens, batteries, body temperature sensors, pulse oximeters, infrared sensors, accelerometer sensors, and circuit boards.

Market Key Developments

The market for remote patient monitoring devices is predicted to rise as new technologies are used by more people. The University of California, San Francisco (UCSF), a biomedical research hub and health system, and Royal Philips, a global health technology company, announced a partnership in May 2021 to develop technology that will enable a contemporary, more streamlined experience for patients and set a new benchmark for healthcare delivery. UCSF will utilize Philips HealthSuite to oversee the development of technologies that customize care, making it easier for patients to pick doctors, access their medical records, and get virtual therapy at home.

In addition, major key players such as Omron Healthcare (headquartered in Japan) are focusing on developing new heart health technologies in order to diversify their product offerings in addition to supplying a wide variety of patient monitoring equipment. For instance, Omron Healthcare announced an extension with clinical development company PhysIQ in February 2019 to incorporate the wearable blood pressure monitor HeartGuide into the remote monitoring platform pinpointIQ. Such integration by manufacturers is anticipated to promote the expansion of the global market for remote patient monitoring devices.

For instance, in April 2020, Seniors stay in touch with their healthcare professionals while securely at home thanks to the debut of three new Remote Patient Monitoring (RPM) devices by 100Plus, the RPM platform for doctors and their patients. Medicare beneficiaries have free access to the 100Plus blood pressure cuff, digital weight scale, and blood glucose monitor, and practices using the 100Plus platform earn around US$ 720 per patient, per year, from the program internationally. Through the course of their care, 100Plus assists doctors in keeping track of their patients and offers data that helps them make clinical choices.Key Takeaways from the Study:

Key Takeaways from the Study:

The players in the global multi-parameter vital sign monitoring market include Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Masimo, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Baxter, OSI Spacelabs, Skanray, SCHILLER and Medtronic PLC, and others.

Report Metric


Market Value in 2022

US$ XX Million

Market Growth Rate (from 2023 to 2031)


Historical Data

2016 & 2031

Base Year


Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Device Type, By Acuity Level, By Monitoring Type, By Patient Group, By End-use, By Region

Key Companies Profiled

Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Masimo, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Baxter, OSI Spacelabs, Skanray, SCHILLER, Medtronic PLC, and others.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.


Target Audience:

  • Supply-side: Manufacturer and distributors.

  • Demand Side: Hospitals, Homecare Settings, Ambulatory Surgical Centres.

  • Regulatory Side: Approved regulatory bodies.

  • Associations and Industry Bodies: India's Central Drug Standard Control Organisation (CDSCO) has Central Licensing Authority (CLA) and State Licensing Authority (SLA), Occupational Safety and Health Administration as well as World Health Organization (WHO), Food Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Health Expenditure (NIH) etc.